Perilacunar remodeling is most prominent as a result of lactation; recent advances further elucidate the molecular players involved and their effect on bone material properties. Of these, vitamin D and calcitonin could be active during aging or osteoporosis. Menopause-related hormonal changes or osteoporosis therapies affect bone material properties and mechanical behavior. However, investigations of lacunar size or osteocyte TRAP activity with age or osteoporosis do not provide clear evidence for or against perilacunar remodeling. While the occurrence and potential role of perilacunar remodeling in aging and osteoporosis progression are largely under-investigated, widespread changes in bone matrix composition in OVX models and following osteoporosis therapies imply osteocytic maintenance of bone matrix. Perilacunar remodeling-induced changes in bone porosity, bone matrix composition, and bone adaptation could have significant implications for bone fracture resistance.
To explore the association of symptoms of sleep-related breathing disorders (SRBD) with asthma control in Indian children.

This study was carried out in the pediatric chest clinic of a tertiary care center in western India. Children from 6 to 18 y of age with a physician-diagnosed case of asthma were included in the study. https://www.selleckchem.com/products/selnoflast.html A validated pediatric sleep questionnaire, SRBD scale, was used to screen the symptoms of SRBD. At the same time, Asthma Control Questionnaire (ACQ) was administered to assess asthma control.

A total of 207 (73% boys) children with asthma were enrolled; the median age was 10 (7, 13) y. Asthma symptoms were well controlled (ACQ ≤ 0.75) in 102 (49.3%) and partly or poorly controlled (ACQ > 0.75) in 105 (50.7%) children. Inattention and/or hyperactivity was the most common SRBD symptom observed in 125 (60.4%) children; daytime sleepiness, mouth breathing, snoring, and night-time breathing problems were observed in 92 (44.5%), 91 (44%), 77 (37.2%), and 68 (32.8%) children, respectively. SRBD score showed a near-linear correlation with ACQ score (r = 0.28, p < 0.001). The score was positive in 52 (25.1%) children. A positive SRBD score was statistically more common in partly or poorly controlled asthma (aOR 2.5; 95% CI 1.2-5.0; p = 0.01). However, the positive score did not show a statistically significant association with gender, being underweight, obesity, allergic rhinitis, compliance to therapy, and inhalation technique.

SRBD symptoms are common in children with asthma. They showed a statistically significant association with partly or poorly controlled asthma. Therefore, it would be interesting to look for SRBD symptoms in children with partly or poorly controlled asthma.
SRBD symptoms are common in children with asthma. They showed a statistically significant association with partly or poorly controlled asthma. Therefore, it would be interesting to look for SRBD symptoms in children with partly or poorly controlled asthma.
To assess whether early total enteral nutrition (80mL/kg/d) started on day 1 of life in hemodynamically stable preterm very-low-birth-weight (VLBW) neonates with the rapid advancement of feeds (20mL/kg/d) help in the earlier achievement of full feeds (180mL/kg/d).

Early total enteral nutrition (intervention) group feeding was started with 80mL/kg/d on the first day in all hemodynamically stable neonates admitted with birth weight of 1000-1499grams, born at 29-33 wk of gestation as determined by first-trimester ultrasonography (USG) or expanded New Ballard Score (NBS) and was advanced by 20mL/kg/d until maximum feeds of 180mL/kg/d were achieved; while in control group feeding was started with 30mL/kg/d on the first day and was advanced by 20mL/kg/d until maximum feeds were achieved. Primary outcome measure was time taken to achieve full feeds; secondary outcomes were duration of hospital stay, necrotizing enterocolitis (NEC), time to regain birth weight, duration of antibiotics, and death.

Sixty VLBW neonates (1000-1499g) with comparable baseline demographics were randomized within 24h of admission to two groups. Early total enteral nutrition intervention group (group I, n= 31) achieved the target of full enteral nutrition at median 6 d; IQR 0 to 7.8 d, a significantly shorter time compared to the controls (n= 29) (median 10 d; IQR 9 to 11.0 d; p= < 0.05).

Early total enteral nutrition started from the first day of life results in significantly less time to achieve full feeds in hemodynamically stable preterm and VLBW infants.
Early total enteral nutrition started from the first day of life results in significantly less time to achieve full feeds in hemodynamically stable preterm and VLBW infants.
Whereas European guidelines recommend adjusting lipid-lowering therapy (LLT) to meet prespecified targets ('treat-to-target') for low-density lipoprotein cholesterol (LDL-C), other guidelines do not ('fire and forget'). In a large observational prospective cohort, we sought to evaluate which strategy could be associated with better cardiovascular outcomes in chronic kidney disease (CKD).

In CKD-REIN, patients (CKD stages 3 and 4) on LLT were categorized according to achievement of LDL-C targets for high and very high cardiovascular risk (< 2.6 and < 1.8mmol/L, respectively) at baseline. Primary outcome was fatal/non-fatal atheromatous cardiovascular disease (CVD). Secondary outcomes were non-atheromatous CVD, atheromatous or non-atheromatous CVD, and major adverse cardiovascular events.

The population comprised 1521 patients (68 ± 12years, 31% women, mean estimated glomerular filtration rate [eGFR] 35mL/min/1.73m
). Overall, 523 (34%) met their LDL-C targets at baseline. Median follow-up was 2.9yed to confirm this theory.
Pediatric exposures to cannabis edibles have been associated with serious adverseeffects, such as respiratory depression. Yet, their incidence and relationship toexposure characteristics are not well defined. We attempt to describe the temporal,demographic, and clinical characteristics of pediatric patients with edible cannabisexposures and examine the relationship between these characteristics and two clinicaloutcomes need for respiratory support and hospital admission.

A retrospective chart review was conducted at a single, tertiary care academic medicalcenter covering a 28-month period. Inclusion criteria were evaluation in the ED, age<18 years at the time of presentation, and physician documented exposure to ediblecannabis. Exclusion criteria were known or suspected co-ingestion of othersubstances.

Thirty-two cases of edible cannabis ingestions were identified. Age <10 years wasassociated with bradypnea, hypertension, hospital admission, and respiratory support.Use of respiratory support was significantly associated with the presence of lethargy,bradypnea, hypercarbia, seizure, and hypertension.
Perilacunar remodeling is most prominent as a result of lactation; recent advances further elucidate the molecular players involved and their effect on bone material properties. Of these, vitamin D and calcitonin could be active during aging or osteoporosis. Menopause-related hormonal changes or osteoporosis therapies affect bone material properties and mechanical behavior. However, investigations of lacunar size or osteocyte TRAP activity with age or osteoporosis do not provide clear evidence for or against perilacunar remodeling. While the occurrence and potential role of perilacunar remodeling in aging and osteoporosis progression are largely under-investigated, widespread changes in bone matrix composition in OVX models and following osteoporosis therapies imply osteocytic maintenance of bone matrix. Perilacunar remodeling-induced changes in bone porosity, bone matrix composition, and bone adaptation could have significant implications for bone fracture resistance. To explore the association of symptoms of sleep-related breathing disorders (SRBD) with asthma control in Indian children. This study was carried out in the pediatric chest clinic of a tertiary care center in western India. Children from 6 to 18 y of age with a physician-diagnosed case of asthma were included in the study. https://www.selleckchem.com/products/selnoflast.html A validated pediatric sleep questionnaire, SRBD scale, was used to screen the symptoms of SRBD. At the same time, Asthma Control Questionnaire (ACQ) was administered to assess asthma control. A total of 207 (73% boys) children with asthma were enrolled; the median age was 10 (7, 13) y. Asthma symptoms were well controlled (ACQ ≤ 0.75) in 102 (49.3%) and partly or poorly controlled (ACQ > 0.75) in 105 (50.7%) children. Inattention and/or hyperactivity was the most common SRBD symptom observed in 125 (60.4%) children; daytime sleepiness, mouth breathing, snoring, and night-time breathing problems were observed in 92 (44.5%), 91 (44%), 77 (37.2%), and 68 (32.8%) children, respectively. SRBD score showed a near-linear correlation with ACQ score (r = 0.28, p < 0.001). The score was positive in 52 (25.1%) children. A positive SRBD score was statistically more common in partly or poorly controlled asthma (aOR 2.5; 95% CI 1.2-5.0; p = 0.01). However, the positive score did not show a statistically significant association with gender, being underweight, obesity, allergic rhinitis, compliance to therapy, and inhalation technique. SRBD symptoms are common in children with asthma. They showed a statistically significant association with partly or poorly controlled asthma. Therefore, it would be interesting to look for SRBD symptoms in children with partly or poorly controlled asthma. SRBD symptoms are common in children with asthma. They showed a statistically significant association with partly or poorly controlled asthma. Therefore, it would be interesting to look for SRBD symptoms in children with partly or poorly controlled asthma. To assess whether early total enteral nutrition (80mL/kg/d) started on day 1 of life in hemodynamically stable preterm very-low-birth-weight (VLBW) neonates with the rapid advancement of feeds (20mL/kg/d) help in the earlier achievement of full feeds (180mL/kg/d). Early total enteral nutrition (intervention) group feeding was started with 80mL/kg/d on the first day in all hemodynamically stable neonates admitted with birth weight of 1000-1499grams, born at 29-33 wk of gestation as determined by first-trimester ultrasonography (USG) or expanded New Ballard Score (NBS) and was advanced by 20mL/kg/d until maximum feeds of 180mL/kg/d were achieved; while in control group feeding was started with 30mL/kg/d on the first day and was advanced by 20mL/kg/d until maximum feeds were achieved. Primary outcome measure was time taken to achieve full feeds; secondary outcomes were duration of hospital stay, necrotizing enterocolitis (NEC), time to regain birth weight, duration of antibiotics, and death. Sixty VLBW neonates (1000-1499g) with comparable baseline demographics were randomized within 24h of admission to two groups. Early total enteral nutrition intervention group (group I, n= 31) achieved the target of full enteral nutrition at median 6 d; IQR 0 to 7.8 d, a significantly shorter time compared to the controls (n= 29) (median 10 d; IQR 9 to 11.0 d; p= < 0.05). Early total enteral nutrition started from the first day of life results in significantly less time to achieve full feeds in hemodynamically stable preterm and VLBW infants. Early total enteral nutrition started from the first day of life results in significantly less time to achieve full feeds in hemodynamically stable preterm and VLBW infants. Whereas European guidelines recommend adjusting lipid-lowering therapy (LLT) to meet prespecified targets ('treat-to-target') for low-density lipoprotein cholesterol (LDL-C), other guidelines do not ('fire and forget'). In a large observational prospective cohort, we sought to evaluate which strategy could be associated with better cardiovascular outcomes in chronic kidney disease (CKD). In CKD-REIN, patients (CKD stages 3 and 4) on LLT were categorized according to achievement of LDL-C targets for high and very high cardiovascular risk (< 2.6 and < 1.8mmol/L, respectively) at baseline. Primary outcome was fatal/non-fatal atheromatous cardiovascular disease (CVD). Secondary outcomes were non-atheromatous CVD, atheromatous or non-atheromatous CVD, and major adverse cardiovascular events. The population comprised 1521 patients (68 ± 12years, 31% women, mean estimated glomerular filtration rate [eGFR] 35mL/min/1.73m ). Overall, 523 (34%) met their LDL-C targets at baseline. Median follow-up was 2.9yed to confirm this theory. Pediatric exposures to cannabis edibles have been associated with serious adverseeffects, such as respiratory depression. Yet, their incidence and relationship toexposure characteristics are not well defined. We attempt to describe the temporal,demographic, and clinical characteristics of pediatric patients with edible cannabisexposures and examine the relationship between these characteristics and two clinicaloutcomes need for respiratory support and hospital admission. A retrospective chart review was conducted at a single, tertiary care academic medicalcenter covering a 28-month period. Inclusion criteria were evaluation in the ED, age<18 years at the time of presentation, and physician documented exposure to ediblecannabis. Exclusion criteria were known or suspected co-ingestion of othersubstances. Thirty-two cases of edible cannabis ingestions were identified. Age <10 years wasassociated with bradypnea, hypertension, hospital admission, and respiratory support.Use of respiratory support was significantly associated with the presence of lethargy,bradypnea, hypercarbia, seizure, and hypertension.
0 Reacties 0 aandelen 43 Views 0 voorbeeld
Sponsor